	US 12,083,167 B2
	Ovotransferrin treatment for the reproductive tract
Jamil Talukder, Memphis, TN (US); Abhijit Ray, Salt Lake City, UT (US); Daniel J. DuBourdieu, Limerick, ME (US); Ajay Srivastava, Menomonie, WI (US); and Rajiv Lall, Menomonie, WI (US)
Assigned to Vets Plus, Inc., Menomonie, WI (US)
Filed by Vets Plus, Inc., Menomonie, WI (US)
Filed on Jan. 12, 2021, as Appl. No. 17/146,859.
Application 17/146,859 is a continuation of application No. 15/954,074, filed on Apr. 16, 2018, granted, now 10,905,748.
Prior Publication US 2021/0128695 A1, May 6, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 38/40 (2006.01); A61K 9/00 (2006.01); A61K 31/12 (2006.01); A61K 31/722 (2006.01); A61K 36/9066 (2006.01); A61P 15/00 (2006.01); A61P 31/04 (2006.01)

CPC A61K 38/40 (2013.01) [A61K 9/0034 (2013.01); A61K 31/12 (2013.01); A61K 31/722 (2013.01); A61K 36/9066 (2013.01); A61P 15/00 (2018.01); A61P 31/04 (2018.01)]

17 Claims

1. A method of treating and protecting a mammal against infectious metritis comprising administering a composition comprising components including a therapeutically effective amount of ovotransferrin.